Back

Sodium-glucose cotransporter 2 inhibitor enhances mitochondrial stress resistance without altering ATP production in patients with ST-elevation myocardial infarction

30 August 2026 (12:15 - 12:45)
Organised by: Logo
Congress Presentation Part of: Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Nattayaporn Apaijai

Chiang Mai University, Chiang Mai (Thailand)

4 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonists outperform SGLT2 inhibitors in cardiorenal protection following acute myocardial infarction treated with PCI: a large-scale propensity score-matched real-world analysis
Doctor I. Zahan (Harefield, GB)
Abstract
Presentation thumbnail
Beta blockers and renin-angiotensin-aldosterone system inhibitors after type 2 myocardial infarction, a target trial emulation study
Doctor A. Gard (Uppsala, SE)
Abstract
Presentation thumbnail
Hemodynamic impact of low-dose dobutamine in patients with acute myocardial infarction at risk of cardiogenic shock – a randomized clinical trial
Doctor S. Holle (Copenhagen, DK)
Abstract
Presentation thumbnail
Comparison of oxidative and tissue stress biomarkers and platelet activation in myocardial infarction treated with prasugrel or ticagrelor
Doctor T. Vichova (Prague, CZ)
Abstract

Access the full session

Session thumbnail
Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2i empagliflozin on left ventricular and mitochondrial function in a porcine model of anthracycline-induced cardiotoxicity
20 May 2023
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction (STEMI) in early-hospital period
25 April 2024
thumbnail
Congress Presentation
Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device
7 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources